Avadel Pharmaceuticals to Report Second Quarter 2018 Results
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
Last avadel pharmaceuticals plc - american depositary shares each representing one ordinary share earnings: 3/12 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
avadel.com
Company Research
Source: GlobeNewswire
DUBLIN, Ireland, July 17, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq:AVDL), today announced it will report its second quarter 2018 financial results on Tuesday, August 7, 2018, before the market open. A conference call to discuss these results has been scheduled for Tuesday, August 7, 2018 at 10:00 a.m. EDT. A question and answer period will follow management's prepared remarks. To access the conference call, investors are invited to dial (844) 388-0559 (U.S. and Canada) or (216) 562-0393 (international). The conference ID number is 7367859. A live audio webcast can be accessed by visiting the Investors section of the Company’s website, www.avadel.com. A replay of the webcast will be archived on Avadel’s website for 90 days following the event. About Avadel Pharmaceuticals plc: Avadel Pharmaceuticals plc (NASDAQ:AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through
Show less
Read more
Impact Snapshot
Event Time:
AVDL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVDL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVDL alerts
High impacting Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share news events
Weekly update
A roundup of the hottest topics
AVDL
News
- Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation Overhang [Seeking Alpha]Seeking Alpha
- Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Craig Hallum from $20.00 to $22.00. They now have a "buy" rating on the stock.MarketBeat
- Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Piper Sandler from $18.00 to $23.00. They now have an "overweight" rating on the stock.MarketBeat
- Avadel Pharmaceuticals plc (NASDAQ: AVDL) had its price target raised by analysts at Oppenheimer Holdings Inc. from $27.00 to $29.00. They now have an "outperform" rating on the stock.MarketBeat
AVDL
Earnings
- 11/8/23 - Miss
AVDL
Sec Filings
- 3/4/24 - Form 8-K
- 3/4/24 - Form 8-K
- 3/4/24 - Form 4
- AVDL's page on the SEC website